360° SearchNetwork Hot Spots Trends Time Series

Mayo Collaborative Services Inc

Type: Company

Name: Mayo Collaborative Services Inc

First reported Apr 16 2013 - Updated Apr 16 2013 - 1 reports

Myriad decision could be a drag on personalized medicine R

After a skeptical Supreme Court hearing, diagnostics and biopharma patent lawyers are sweating the outcome of Association for Molecular Pathology vs. Myriad Genetics, in which the Court could decide whether or not swatches of genes are patentable.At issue ... [Published Medical Marketing And Media - Apr 16 2013]

Entities: Patent, Gila Monster, Diagnostic, Mayo Collaborative Services Inc

First reported Apr 15 2013 - Updated Apr 15 2013 - 3 reports

Supreme Court hears gene patentability arguments

The court will decide whether two genetic sequences linked to breast and ovarian cancer constitute unpatentable “natural law”The Supreme Court on Monday will hear oral arguments from a group of doctors and patients who contend that patents on human genes ... [Published Inside Counsel - Apr 15 2013]

Entities: Patent, Supreme Court, Mayo Collaborative Services Inc, Breast Cancer

First reported Mar 27 2013 - Updated Mar 27 2013 - 1 reports

Prometheus Laboratories Inc

Is Lack of Preemption the Key for the Supreme Court to Decide in Myriad's Favor?

By Kevin E. Noonan -- The U.S. Supreme Court will hear arguments in Association for Molecular Pathology v. Myriad Genetics, Inc. on April15th, and the parties and their different cadres of amici have submitted briefs of varying degrees of helpfulness ... [Published Patent Docs - Mar 27 2013]

Entities: Supreme Court, Mayo Collaborative Services Inc, Prometheus Laboratories Inc, Molecular Pathology, Myriad Genetics Inc

First reported Feb 08 2013 - Updated Feb 09 2013 - 2 reports

What Software Is Patentable? Federal Court To Consider In CLS Bank Rehearing

Editor’s note: Anthony Lombardi practices litigation and patent prosecution at Finnegan, Henderson, Farabow, Garrett & Dunner, LLP. He also provides strategic counseling to clients regarding pre-litigation, portfolio development, patent monetization, ... [Published TechCrunch - Feb 08 2013]

Entities: Patent, Invention, Federal, courts

First reported Jan 31 2013 - Updated Jan 31 2013 - 1 reports

Duke University School of Law

Online symposium announcement: Are genes patentable?

In early February, the blog will host an online symposium to discuss how the Court should rule (and why) on the question presented by Association for Molecular Pathology v. Myriad Genetics, Inc. : whether human genes are patentable. In this case, respondent ... [Published SCOTUSblog - Jan 31 2013]

Entities: Patent, Myriad Genetics Inc, Mayo Collaborative Services Inc, McDonnell Boehnen Hulbert & Berghoff, Duke University School of Law

First reported Dec 21 2012 - Updated Dec 21 2012 - 1 reports

Friday round-up

Yesterday’s coverage continued to focus on Judge Robert Bork, who passed away on Wednesday. In addition to the coverage collected in yesterday’s round-up , other coverage comes from Akhil Amar at Slate , Dylan Matthews at The Washington Post’s Wonkblog ... [Published SCOTUSblog - Dec 21 2012]

Entities: EN BANC, Greenhouse Gas, Michelle Olsen, Mayo Collaborative Services Inc

Quotes

Trade group BIO said in a statement: "The Supreme Court is being asked to categorically strike down a large class of patents based on the purported marketplace behavior of a single genetic diagnostic testing company. We are concerned that this case could potentially affect many biotech companies whose activities have nothing to do with the clinical testing services that are at issue in this litigation ... The term 'gene patent' is misleading, because patents cannot cover the genes that exist in humans, plants, animals or microbes. Contrary to what has been said, patents confer no ownership over genes. Nor have the patents which are allowed stifled research, harmed patients, or interfered with medical care."

Myriad decision could be a drag on personalized medicine R [Published Medical Marketing And Media - Apr 16 2013]

More Content

sort by: Date \| Relevance
Thoughts on the Supreme Court’s Long Awaited De... [Published For The Defense - May 18 2013]
Q&A With LeClairRyan's Michael Goldman [Published LeClairRyan - May 14 2013]
IP: Business methods, diagnostics and abstract ... [Published Inside Counsel - Apr 23 2013]
After Myriad Oral Argument, Supreme Court Set t... [Published Biotech Blog - Apr 18 2013]
After Myriad Oral Argument, Supreme Court Set t... [Published JD Supra - Apr 16 2013]
Myriad decision could be a drag on personalized... [Published Medical Marketing And Media - Apr 16 2013]
Supreme Court hears gene patentability arguments [Published Inside Counsel - Apr 15 2013]
Justices Seem Wary of Bold Action in Gene Paten... [Published New York Times - Apr 15 2013]
Justices Tackle the Patenting of Human Genes [Published New York Times - Apr 15 2013]
Patent and Tech Transfer Sessions at 2013 BIO I... [Published Patently BIOtech - Apr 08 2013]
Patent and Tech Transfer Sessions at 2013 BIO I... [Published I Am Biotech - Apr 08 2013]
Is Lack of Preemption the Key for the Supreme C... [Published Patent Docs - Mar 27 2013]
What Software Is Patentable? Federal Court To C... [Published TechCrunch - Feb 08 2013]
What Software Is Patentable? Federal Court To C... [Published TechCrunch Europe - Feb 08 2013]
Nothing under the sun that is made of man [Published SCOTUSblog - Feb 07 2013]
Another case of certiorari improvidently granted [Published SCOTUSblog - Feb 06 2013]
Questions that will remain unanswered from the ... [Published SCOTUSblog - Feb 06 2013]
The practicalities of patenting a gene [Published SCOTUSblog - Feb 05 2013]
The “runcible” product of nature doctrine [Published SCOTUSblog - Feb 04 2013]
Patentable subject matter at the Supreme Court:... [Published SCOTUSblog - Feb 04 2013]
Online symposium announcement: Are genes patent... [Published SCOTUSblog - Jan 31 2013]
Friday round-up [Published SCOTUSblog - Dec 21 2012]
Petitions to watch \| Conference of November 30,... [Published SCOTUSblog - Nov 28 2012]

Blogs

sort by: Date \| Relevance
After Myriad Oral Argument, Supreme Court Set t... [Published Biotech Blog - Apr 18 2013] Copyright © thinkBiotech This is a guest post by Morrison & Foerster ‘s Marc A. Hearron, James J. Mullen, III and Matthew I. Kreeger. Do you have a response to this post? Sound off in the comments section below. The Supreme Court of the United ...
Patent and Tech Transfer Sessions at 2013 BIO I... [Published Patently BIOtech - Apr 08 2013] Patent and Technology Transfer sessions feature prominently at the 2013 BIO International Convention in Chicago from April 22-25, 2013. Topics cover developing patent and tech transfer issues in the U.S. and internationally. Many of the sessions provide ...
Patent and Tech Transfer Sessions at 2013 BIO I... [Published I Am Biotech - Apr 08 2013] Patent and Technology Transfer sessions feature prominently at the 2013 BIO International Convention in Chicago from April 22-25, 2013. Topics cover developing patent and tech transfer issues in the U.S. and internationally. Many of the sessions provide ...
Is Lack of Preemption the Key for the Supreme C... [Published Patent Docs - Mar 27 2013] By Kevin E. Noonan -- The U.S. Supreme Court will hear arguments in Association for Molecular Pathology v. Myriad Genetics, Inc. on April15th, and the parties and their different cadres of amici have submitted briefs of varying degrees of helpfulness ...
What Software Is Patentable? Federal Court To C... [Published TechCrunch - Feb 08 2013] Editor’s note: Anthony Lombardi practices litigation and patent prosecution at Finnegan, Henderson, Farabow, Garrett & Dunner, LLP. He also provides strategic counseling to clients regarding pre-litigation, portfolio development, patent monetization, ...